SHI Xiao-yi, ZHU Ming-min, JIE Li-gang, et al. Effect of Compound Tufuling Granules on Physical and Chemical Indexes and Protein Levels in Hyperuricemia Rats with Syndrome of Phlegm-Dampness[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(15): 100-105.
SHI Xiao-yi, ZHU Ming-min, JIE Li-gang, et al. Effect of Compound Tufuling Granules on Physical and Chemical Indexes and Protein Levels in Hyperuricemia Rats with Syndrome of Phlegm-Dampness[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(15): 100-105. DOI: 10.13422/j.cnki.syfjx.2016150100.
Objective: To observe the effect of compound Tufuling granules (CTG) on physical and chemical indexes and protein levels in hyperuricemia (HUA) rats with syndrome of phlegm-dampness. Method: Forty-eight rats were randomly divided into blank group
model group
western medicine group(febuxostat
4 mg·kg-1)
CTG low-dose group
CTG mid-dose group and CTG high-dose group(1
2
4 g·kg-1). The rats in all groups except blank group received high-fat diets combined with hypoxanthine by intragastric administration and potassium oxygen by intraperitoneal injecting to establish hyperuricemia (HUA) rat models with syndrome of phlegm-dampness
and then the rats were given with appropriate treatment. Thirty days later
the changes of behavioristics and serum uric acid (UA)
alanine aminotransferase (ALT)
aspartate aminotransferase (AST)
triglyceride (TG)
low density lipoprotein (LDL)
protein levels of renal urate reabsorption transporter 1 (mURAT1) and liver pathology of all the rats were detected. Result: In model group
the levels of UA
ALT
AST
TG
LDL and mURAT1 protein levels were significantly higher than those in blank group (P<0.05). In CTG high-dose group
the levels of UA
ALT
AST
TG
LDL and mURAT1 protein levels were significantly lower than those in model group (P<0.05)
and the scores of syndrome of phlegm-dampness were significantly improved (P<0.05). The difference was not significant in levels of AST
TG
and LDL between CTG mid-dose group and model group
but the effects on other levels in mid-dose group were similar with those in CTG high-dose group. There was no significant difference between CTG low-dose group and model group. In western medicine group
only the level of UA was significantly lower than that of model group (P<0.05)
and there was no significant difference in the level of UA between western medicine group and CTG high-dose group. Liver damages were observed in liver pathology of model group. Conclusion: CTG may reduce the level of serum uric UA in HUA rats with phlegm-dampness
improve the constitution of phlegm-dampness
liver function and blood lipids as compared with the western medicine
and the mechanism may be associated with down-regulating the protein levels of renal mURAT1.